Matt Wade, Author at BioPharmaJournal

392 POSTS 0 COMMENTS

Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.

GameStop (NYSE:GME) shorts could to be crushed by Apes

Matt Wade - March 21, 2023 0

Axon Enterprise Inc (NASDAQ:AXON) keep surging and here’s why

Matt Wade - March 19, 2023 0

This is where TSLA stock is heading next and may not...

Matt Wade - March 2, 2023 0

Bridger Aerospace Group Holdings (BAER) stock sparks investor interest and optimism...

Matt Wade - February 25, 2023 0

Rolls-Royce (RYCEY) shares gain double digits post annual results

Matt Wade - February 23, 2023 0

Penny Stocks In Focus (IREN,RDW,ARQQ,AMAM,VERU)

Matt Wade - February 16, 2023 0

Reason why ReShape Lifesciences Stock (RSLS) is surging

Matt Wade - February 3, 2023 0

C3.ai Inc (NYSE:AI) gains over 30% in 3 days on strength...

Matt Wade - February 1, 2023 0

SOBR Safe Inc. (SOBR) storms Wall Street with over 60% gains

Matt Wade - January 31, 2023 0

BigBear.ai Holdings Inc (BBAI) chart shows bullish action

Matt Wade - January 30, 2023 0

12 3...40 Page 1 of 40

Invesco QQQ Trust Series 1 (NASDAQ:QQQ) continues higher as banking fears...

Ash K - March 30, 2023 0

The QQQ’s are finally starting to hold above the major $309 level and are continuing higher this morning. Bank fears are being...

Stocks in Focus as short interest rises (TTCF,BYND,ALLO,EDIT,SANA,ARQT,IBRX)

March 28, 2023

Silvergate Capital Corp (NYSE:SI) Dramatic Surge: Exploring Potential Causes and Future...

March 24, 2023

GameStop (NYSE:GME) shorts could to be crushed by Apes

March 21, 2023

Axon Enterprise Inc (NASDAQ:AXON) keep surging and here’s why

March 19, 2023

Matt Wade

Recent Post